We are live on
!
Find out more
KM
Kalos Management Portfolio holdings
AUM
$46.6M
1-Year Est. Return
11.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.81%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
–
AUM
$155M
AUM Growth
-$50.6M
(-25%)
Cap. Flow
-$61.8M
Cap. Flow
% of AUM
-39.95%
Top 10 Holdings %
Top 10 Hldgs %
29.7%
Holding
194
New
–
Increased
10
Reduced
142
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.03M |
| 2 |
RTL
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
|
+$284K |
| 3 |
BRSP
BrightSpire Capital
BRSP
|
+$208K |
| 4 |
Global Net Lease
GNL
|
+$117K |
| 5 |
CVS Health
CVS
|
+$113K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$5.99M |
| 2 |
VER
VEREIT, Inc.
VER
|
+$3.63M |
| 3 |
Schwab U.S Small- Cap ETF
SCHA
|
+$3.62M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$3.49M |
| 5 |
Invesco S&P 500 Equal Weight Technology ETF
RSPT
|
+$3.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Healthcare | 11% |
| 3 | Financials | 7.87% |
| 4 | Consumer Discretionary | 5.98% |
| 5 | Real Estate | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares MSCI EAFE ETF
EFA
$78B
| $238K | 0.15% |
3,677
-857
| -19% | -$54K |
|
127
FedEx
FDX
$72.7B
| $236K | 0.15% |
1,304
-309
| -19% | -$54.6K |
|
128
BioCryst Pharmaceuticals
BCRX
$2.28B
| $223K | 0.14% |
27,443
-1,257
| -4% | -$10.8K |
|
129
Mastercard
MA
$502B
| $223K | 0.14% |
948
-274
| -22% | -$58.9K |
|
130
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $218K | 0.14% |
1,506
-226
| -13% | -$31.5K |
|
131
Qualcomm
QCOM
$155B
| $212K | 0.14% |
3,729
-525
| -12% | -$28.3K |
|
132
Ares Capital
ARCC
$13.5B
| $210K | 0.14% |
12,254
-2,403
| -16% | -$40.3K |
|
133
Vanguard Morningstar Value ETF
VTV
$188B
| $205K | 0.13% |
1,910
-375
| -16% | -$39.5K |
|
134
United Natural Foods
UNFI
$3.08B
| $203K | 0.13% |
15,416
-6,248
| -29% | -$84.3K |
|
135
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $196K | 0.13% |
5,190
-810
| -14% | -$29.9K |
|
136
Chevron
CVX
$392B
| $194K | 0.13% |
1,575
-272
| -15% | -$32.2K |
|
137
Vanguard Morningstar Growth ETF
VUG
$220B
| $188K | 0.12% |
7,236
-1,872
| -21% | -$46.2K |
|
138
SPDR Gold Trust
GLD
$131B
| $187K | 0.12% |
1,539
-180
| -10% | -$22.2K |
|
139
Meta Platforms (Facebook)
META
$1.42T
| $186K | 0.12% |
1,115
-294
| -21% | -$46.8K |
|
|
HTGM
140
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $159K | 0.1% |
354
-59
| -14% | -$25.8K |
|
141
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
| $152K | 0.1% |
9,571
-1,684
| -15% | -$26.4K |
|
|
PHK
142
PIMCO High Income Fund
PHK
$867M
| $148K | 0.1% |
16,477
-4,405
| -21% | -$38.3K |
|
|
PRTK
143
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $142K | 0.09% |
26,567
+2,117
| +9% | +$13.7K |
|
|
UDF
144
DELISTED
UNITED DEV FDG IV COM SHS OF BENE INT (TX)
UDF
| $142K | 0.09% |
26,666
-10,540
| -28% | -$56.1K |
|
145
Gyre Therapeutics
GYRE
$641M
| $130K | 0.08% |
2,151
-290
| -12% | -$18.6K |
|
146
GE Aerospace
GE
$374B
| $123K | 0.08% |
2,484
-783
| -24% | -$36.9K |
|
147
Cytosorbents Corp
CTSO
$22.7M
| $106K | 0.07% |
14,108
-592
| -4% | -$4.61K |
|
148
DigitalBridge
DBRG
$2.93B
| $105K | 0.07% |
4,935
+229
| +5% | +$5.11K |
|
|
FOLD
149
DELISTED
Amicus Therapeutics
FOLD
| $104K | 0.07% |
7,656
-3,094
| -29% | -$37.8K |
|
150
CSX Corp
CSX
$93.4B
| – | – |
-10,308
| Closed | -$259K |
|
Similar funds
IM
UCIG
KP
NH
DCM
VCM
FGIM
WGRM
Kalos Management's Q1 2019 Portfolio in Review
As of Q1 2019, Kalos Management held 194 positions worth $155M, down 25% from $205M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Kalos Management withdrew a net $61.8M in Q1 2019, closing 41 positions and reducing 142 holdings. Its most notable exit was Schwab US Large- Cap ETF, an estimated $5.99M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Kalos Management added an estimated $2.03M to iShares Core S&P 500 ETF.
- Kalos Management added most to iShares Core S&P 500 ETF in Q1 2019, an estimated $2.03M increase.
- Kalos Management's biggest Q1 2019 reduction was VEREIT, Inc., cutting an estimated $3.63M.
- Kalos Management fully exited Schwab US Large- Cap ETF in Q1 2019, selling an estimated $5.99M.
- Kalos Management's ten largest holdings make up 30% of its $155M portfolio in Q1 2019.
- Kalos Management opened 0 new positions and closed 41 in Q1 2019.
- Kalos Management's portfolio value fell 25% quarter-over-quarter to $155M.
Based on Kalos Management's 13F filing for Q1 2019, filed 15 May 2019.